Neudle.com: depakene

Differential
(Click to cross reference)

abortion, spontaneous

absence

acquired immunodeficiency syndrome dementia complex

adverse drug reaction

anticonvulsants, bioavailability

anticonvulsants, blood level determination of

anticonvulsants, cognitive function with

anticonvulsants, compliance

anticonvulsants, discontinuation in seizure-free epileptics

anticonvulsants, dosage

anticonvulsants, effectiveness

anticonvulsants, enzyme inducing

anticonvulsants, hypersensitivity syndrome

anticonvulsants, loading dose

anticonvulsants, mechanism of action of

anticonvulsants, parenteral administration

anticonvulsants, pharmacokinetics

anticonvulsants, rate of administration

anticonvulsants, saliva level determination

anticonvulsants, selection of

anticonvulsants, teratogenicity of

anticonvulsants, untoward effects of

Asperger's syndrome

aspirin

asterixis

attention deficit disorder with hyperactivity

basal ganglia, lesion, bilateral

behavioral disorder

benzodiazepine

beta adrenergic blocker

blood dyscrasias, neurologic findings with

bone density

bone loss

bone marrow suppression

carnitine deficiency myopathy

cerebral cortical atrophy

cerebrospinal fluid, hydroxyindoleacetic acid, 5(5-HIAA)

cerebrovascular accident

cerebrovascular accident, infancy and childhood

chorea, Sydenham's, recurrent

chorea, treatment of

cleft lip

cleft palate

Clinical Pathologic Conference(C.P.C.)

congenital birth defects

congenital deformities

congenital heart disease

congenital malformation

controversies in neurology

developmental disability

developmental evaluation

developmental retardation

DHE

diabetes mellitus

dietary supplement

differential diagnosis

dilantin

dilantin, factors influencing metabolism of

dilantin, saliva level

dilantin, serum level

dilantin, toxicity

drowsiness

drug induced neurologic disorders

dyssynergia cerebellaris myoclonica

electroencephalogram, abnormalities of

electroencephalogram, video monitoring with

embryogenesis

emergencies, neurologic

encephalitis

encephalitis, focal

encephalitis, unknown etiology

epilepsia partialis continua

epilepsy referral centers

fetal valproate syndrome

fetus

folic acid

fortification spectra

fosphenytoin

frovatriptan

gabapentin

gamma amino butyric acid

hallucination, visual

headache

headache, exertional

headache, intractable

headache, laughing

headache, precipitating factors

headache, severe

headache, sudden onset of

headache, throbbing

headache, treatment of

hearing loss

heat intolerance

hemiballismus

hepatic encephalopathy

hepatic failure

hepatitis

hepatolenticular degeneration, non-Wilsonian

hiccoughs

Horner's syndrome

human immunodeficiency virus type 1

Huntington's chorea

hyperactivity

hyperammonemic encephalopathy

hypersensitivity reaction

hyponatremia

hypospadias

hypotension, systemic

hypothalamus

hypothalamus, disturbance of

hypothermia

hypotonia

iatrogenic neurologic disorders

intelligence quotient

intelligence testing in children

intrauterine

intravenous

jaundice

juvenile myoclonus epilepsy

lamotrigine

laughing

leukopenia

level of consciousness, decreased

liver function enzymes

liver transplantation

lorazepam

malabsorption

malabsorption syndrome

malformation, CNS, congenital

manic-depressive

menses, irregular

mental retardation

mental status, abnormal

migraine, intractable

migraine, menses

migraine, prophylaxis

migraine, treatment of

migraine, visual symptoms in

movement disorder, drug induced

movement disorder, treatment of

MRI

MRI, abnormal

MRI, diffusion weighted

MRI, negative

myelopathy

myelopathy, chronic progressive

myoclonus, post anoxic

myoclonus, segmental

myoclonus, sleep

myoclonus, stimulus sensitive

myoclonus, treatment of

neoplasm, metastatic to CNS

neoplasm, primary intracerebral

neoplasm, primary of CNS

nerve block

nerve conduction studies

neurologic disease, diagnoses of

neuropathy

neuropathy, diabetic

neuropathy, painful

neuropathy, peripheral, treatment

neurosis

neurotoxin

neutropenia

nonsteroidal anti-inflammatory drug

nutritional deficiency

obesity

ocular myoclonus

old age, neurology of

ornithine transcarbamylase deficiency

pain, management of chronic

palatal myoclonus

pancreatitis

paresthesias

paresthesias, generalized

Parkinson disease

Parkinson disease, drug induced

Parkinsonism syndrome

pleocytosis of cerebrospinal fluid

pleocytosis of cerebrospinal fluid, neutrophilic

polycystic ovarian syndrome

precipitating factors

pregnancy, anticonvulsants during

pregnancy, neurologic complications in

prenatal

prevention of neurologic disorders

prognosis

progressive infantile poliodystrophy

progressive neurologic disorder

propofol

propranolol

protein C deficiency

psychological testing

psychological testing, children

risk-benefit assessment

seizure, breakthrough

seizure, children

seizure, classification of

seizure, diagnosis of

seizure, differential diagnosis of

seizure, driving with

seizure, drug resistance

seizure, intractable, treatment of

seizure, medication failure

seizure, minor motor

seizure, non-treatment of

seizure, paradoxical

seizure, petit mal

seizure, pregnancy

seizure, prevention of

seizure, prognosis in adults

seizure, prognosis in childhood

seizure, psychomotor-temporal lobe

seizure, reading induced

seizure, recurrent

seizure, stimulus sensitive

seizure, tonic-clonic

seizure, treatment of

seizure, treatment of, first

seizure, treatment of, monotherapy

seizure, treatment of, polytherapy

seizure, withdrawal

seizure, women

seizure, workup of

selective serotonin reuptake inhibitors

sensorineural hearing loss

sensory loss

serum glutamic oxaloacetic transaminase

single photon emission computed tomography

skin, lesions in neurologic disorders

sodium valproate

sodium valproate, intravenous

sodium valproate, toxicity

somatosensory evoked potentials

somnolence

spina bifida

spinal cord, lesion of

startle reaction

status epilepticus

status epilepticus, intractable

status epilepticus, myoclonic

status epilepticus, nonconvulsive

status epilepticus, recurrent

testosterone, serum, elevated

thermoregulatory disorder

treatment of neurologic disorder

tremor

tricyclic antidepressant

trigeminal neuralgia

trigeminal neuralgia, treatment of

triptans

urea-cycle enzymopathies

weakness, generalized

Showing articles 50 to 100 of 191 << Previous Next >>

Valproate Embryopathy in Three Sets of Siblings: Further Proof of Hereditary Susceptibility
Neurol 59:630-633, Malm,H.,et al, 2002

Weight Change Associated with Valproate and Lamotrigine Monotherapy in Patients with Epilepsy
Neurol 56:172-177, Biton,V.,et al, 2001

Intravenous Valproic Acid for Myoclonic Status Epilepticus
Neurol 54:1201, Sheth,R.D. & Gidal,B.E., 2000

Intravenous Valproate in Pediatric Epilepsy Patients with Refractory Status Epilepticus
Neurol 54:2188-2189, Uberall,M.A.,et al, 2000

Epilepsy in Elderly People
Lancet 355:1441-1446, Stephen,L.J.&Brodie,M.J., 2000

Valproate, Hyperandrogenism, and Polycystic Ovaries
Arch Neurol 57:1064-1068, Isojarvi,J.I.T. & Tapanainen,J.S., 2000

Hypothermia and Thermoregulatory Derangements Induced by Valproic Acid
Neurol 55:150-151, Zachariah,S.B. et al, 2000

Intravenous Valproate is Well Tolerated in Unstable Patients with Status Epilepticus
Neurol 55:722-724, Sinha,S. & Naritoku,D.K., 2000

Protein C Deficiency Related to Valproic Acid Therapy: A Possible Association with Childhood Stroke
J Pediatr 137:714-718, Gruppo,R.,et al, 2000

Valproate-Induced Hyperammonemic Encephalopathy in the Presence of Topiramate
Neurol 54:230-232, Hamer,H.M.,et al, 2000

Treatment of Absence Status with Intravenous Valproate
Neurol 52:889-890, Alehan,F.K.,et al, 1999

Clumsiness, Confusion, Coma, and Valproate
Lancet 353:1408, Ellaway,C.J.,et al, 1999

Intractable Epilepsy
Lancet 353:1238, Shuper,A.,et al, 1999

Antiepileptic Drug Regimens and Major Congenital Abnormalities in the Offspring
Ann Neurol 46:739-746, Samren,E.B.,et al, 1999

Antiepileptics and Blood Dyscrasias: A Cohort Study
Pharmacotherapy 18:1277-1283, Blackburn,S.C.F.,et al, 1998

Hyponatremia Due to Sodium Valproate
Ann Neurol 43:265-267, Branten,A.J.W.,et al, 1998

Status Epilepticus
NEJM 338:970-976, Lowenstein,D.H.&Alldredge,B.K., 1998

Medically Induced Gingival Hyperplasia
Mayo Clin Proc 73:1196-1199, Meraw,S.J. &Sheridan,P.J., 1998

Successful Treatment of Persistent Migraine Aura with Divalproex Sodium
Neurol 48:261-262, Rothrock,J.F., 1997

A Comparison of Divalproex with Propranolol and Placebo for the Prophylaxis of Migraine Without Aura
Arch Neurol 54:1141-1145, Kaniecki,R.G., 1997

Risk of Serious Cutaneous Disorders after Initiation of Use of Phenytoin, Carbamazepine, or Sodium Valproate
Neurol 49:542-546, Tennis,P.&Stern,R.S., 1997

Antiepileptic Drugs
NEJM 334:168-175, Brodie,M.J.&Dichter,M.A., 1996

Valproic Acid Hepatic Fatalities. III. U. S. Experience Since 1986
Neurol 46:465-469, Bryant,A.E.&Dreifuss,F., 1996

Random Comp Monother Trial of Phenobarb, Phenytoin, Carbamazepine, or Sod Valp for Newly Dx Child Epilep
Lancet 347:709-713, deSilva,M.,et al, 1996

Obesity and Endocrine Disorders in Women Taking Valproate for Epilepsy
Ann Neurol 39:579-584, 5591996., Isojarvi,J.I.T.,et al, 1996

Reversible Parkinsonism and Cognitive Impairment with Chronic Valproate Use
Neurol 47:626-635, Armon,C.,et al, 1996

A Randomized, Blinded, Placebo-Controlled Trial of Divalproex Sodium Prophylaxis in Adults with Newly Diagnosed Brain Tumors
Neurol 46:985-991, Glantz,M.J.,et al, 1996

Safety of Intravenous Valproate
Ann Neurol 38:670-674, Devinsky,O.,et al, 1995

Reversible Dementia and Apparent Brain Atrophy During Valproate Therapy
Ann Neurol 38:687-691, Papazian,O.,et al, 1995

Drugs for Migraine
The Medical Letter 37:17-20, , 1995

Migraine Prophylaxis with Divalproex
Arch Neurol 52:281-286, Mathew,N.T.,et al, 1995

Phenobarbitone, Phenytoin, Carbamazepine, or Sodium Valproate for Newly Diagnosed Adult Epilepsy:A Randomized Monotherapy Trial
JNNP 58:44-50, Heller,A.J.,et al, 1995

Rational Polypharmacy in the Treatment of Epilepsy
(Ed) , Neurol (suppl) 45:S1-S38., Wilder,B.J., 1995

Drugs for Epilepsy
The Medical Letter, 37:37-401995., , 1995

Reading-Induced Absence Seizures
Neurol 45:1623-1624, Singh,B.,et al, 1995

Comparative Cognitive Effects of Phenobarbital, Phenytoin, and Valproate in Healthy Adults
Neurol 45:1494-1499, Meador,K.J.,et al, 1995

Anticonvulsant Drugs for Management of Pain:A Systematic Review
BMJ 311:1047-1052, McQuay,H.,et al, 1995

Valproic Acid-Induced Hyperammonemic Encephalopathy:MR Appearance
AJNR 15:1779-1781, Baganz,M.D.&Dross,P.E., 1994

Sodium Valproate Has a Prophylactic Effect in Migraine without Aura
Neurol 44:647-651, Jensen,R.,et al, 1994

A Multicentre Comparative Trial of Sodium Valproate and Carbamazepine in Adult Onset Epilepsy
JNNP 57:682-687, Richens,A.,et al, 1994

Does Carnitine Admin Inprove Symptoms Attributed to Anticonvulsant Meds? Double-Blinded Study
Pediatrics 93:893-895, 8911994., Freeman,J.M.,et al, 1994

Choreiform Movements Associated with the Use of Valproate
Arch Neurol 51:702-704, Lancman,M.E.,et al, 1994

Cortical Myoclonus in Huntington's Disease
Movement Disorders 9:633-641, Thompson,P.D.,et al, 1994

Juvenile Myoclonic Epilepsy
Arch Neurol 50:594-598, Grunewald,R.A.&Panayiotopoulos,C.P., 1993

Polycystic Ovaries and Hyperandrogenism in Women Taking Valproate for Epilepsy
NEJM 329:1383-1388, Isojarvi,J.I.T.,et al, 1993

Withdrawal of Antiepileptic Medication in Children-Effects of Congit Funct Multicenter Holmfrid Study
Aldenkamp. A. P. , et al, neurol 43:41-50., , 1993

Typical Absence Seizures in Adults:Clinical, EEG, Video-EEG Findings & Diagnostic/Syndr Consider
JNNP 55:1002-1008, Panayiotopoulos,C.P.,et al, 1992

Safety and Efficacy of Valproate and Carbamazepine in the Treatment of Complex Partial Seizures
J Epilepsy 5:149-152, So,E.L.,et al, 1992

Delayed Diagnosis of Juvenile Myoclonic Epilepsy
JNNP 55:497-499, Grunewald,R.A.,et al, 1992

Cluster Headache
Neurol 42 (Suppl 2) :22-31992., Mathew,N.T., 1992

Showing articles 50 to 100 of 191 << Previous Next >>